# Motif Bio plc Will Present at IDWeek 2017 – Infectious Diseases Conference

- Link: https://www.directorstalkinterviews.com/motif-bio-plc-will-present-idweek-2017-infectious-diseases-conference/412730665
- Published: 2017-06-22T07:11:34+01:00
- Author: Giles Arbor

**Motif Bio plc** (LON:MTFB), the clinical stage biopharmaceutical company specialising
in developing novel antibiotics, announced today that Dr. David Huang, Chief Medical
Officer at Motif Bio, has been invited to present a clinical development overview
of iclaprim during the formal Symposia session at IDWeek 2017 on October 5, 2017.
In addition, Dr. Huang will lead a “Meet-the-Professors Session” in a clinically
oriented Q&A session on October 6, 2017.

IDWeek is the combined annual meeting of the Infectious Diseases Society of America,
Society for Healthcare Epidemiology of America, HIV Medicine Association and Pediatric
Infectious Diseases Society. The Symposia session is focused on clinical programmes
in late clinical development and closest to regulatory approval.

> **Commenting on the invitation David Huang, CMO at Motif Bio Plc said:** “IDWeek
> is a major event for infectious disease professionals and I am delighted that 
> the IDWeek Committee have selected iclaprim for presentation. I look forward to
> presenting the positive data from the REVIVE-1 trial. We believe these data suggest
> iclaprim may serve as an important differentiated antibiotic option in an era 
> of emerging antibiotic resistant infections.”

Share on: